221 related articles for article (PubMed ID: 33937042)
1. The Sensitivity Prediction of Neoadjuvant Chemotherapy for Gastric Cancer.
Sun J; Wang X; Zhang Z; Zeng Z; Ouyang S; Kang W
Front Oncol; 2021; 11():641304. PubMed ID: 33937042
[TBL] [Abstract][Full Text] [Related]
2. Prediction of neoadjuvant chemotherapeutic efficacy in patients with locally advanced gastric cancer by serum IgG glycomics profiling.
Qin R; Yang Y; Chen H; Qin W; Han J; Gu Y; Pan Y; Cheng X; Zhao J; Wang X; Ren S; Sun Y; Gu J
Clin Proteomics; 2020; 17():4. PubMed ID: 32042279
[TBL] [Abstract][Full Text] [Related]
3. The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy.
Li Z; Li S; Ying X; Zhang L; Shan F; Jia Y; Ji J
Gastric Cancer; 2020 May; 23(3):540-549. PubMed ID: 32072387
[TBL] [Abstract][Full Text] [Related]
4. Treatment Response Predictors of Neoadjuvant Therapy for Locally Advanced Gastric Cancer: Current Status and Future Perspectives.
Sato Y; Okamoto K; Kawaguchi T; Nakamura F; Miyamoto H; Takayama T
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884916
[TBL] [Abstract][Full Text] [Related]
5. Changes in Expression of Multiple Checkpoint Molecules and Infiltration of Tumor Immune Cells after Neoadjuvant Chemotherapy in Gastric Cancer.
Yu Y; Ma X; Zhang Y; Zhang Y; Ying J; Zhang W; Zhong Q; Zhou A; Zeng Y
J Cancer; 2019; 10(12):2754-2763. PubMed ID: 31258783
[TBL] [Abstract][Full Text] [Related]
6. 15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer.
Hu M; Li K; Maskey N; Xu Z; Peng C; Tian S; Li Y; Yang G
Int J Clin Exp Pathol; 2015; 8(6):6910-8. PubMed ID: 26261578
[TBL] [Abstract][Full Text] [Related]
7. MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer.
Seierstad T; Hole KH; Grøholt KK; Dueland S; Ree AH; Flatmark K; Redalen KR
Br J Radiol; 2015 Jul; 88(1051):20150097. PubMed ID: 25899892
[TBL] [Abstract][Full Text] [Related]
8. Decreased FOXP3+ and GARP+ Tregs to neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancer.
Li K; Chen F; Xie H
Onco Targets Ther; 2016; 9():3525-33. PubMed ID: 27366089
[TBL] [Abstract][Full Text] [Related]
9. A comparative analysis on clinical efficacy of FOLFOX6 regimen and DCF regimen as neoadjuvant chemotherapy combined with radical gastrectomy in treating advanced gastric cancer.
Tai Q; Shao H; Liu Y; Li E; Zhao R
J BUON; 2019; 24(5):2006-2012. PubMed ID: 31786868
[TBL] [Abstract][Full Text] [Related]
10. Change in volume parameters induced by neoadjuvant chemotherapy provide accurate prediction of overall survival after resection in patients with oesophageal cancer.
Tamandl D; Gore RM; Fueger B; Kinsperger P; Hejna M; Paireder M; Haug A; Schoppmann SF; Ba-Ssalamah A
Eur Radiol; 2016 Feb; 26(2):311-21. PubMed ID: 26040648
[TBL] [Abstract][Full Text] [Related]
11.
Vallius T; Hynninen J; Kemppainen J; Alves V; Auranen K; Matomäki J; Oksa S; Virtanen J; Grénman S; Auranen A; Seppänen M
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1224-1232. PubMed ID: 29476227
[TBL] [Abstract][Full Text] [Related]
12. The predictors of response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer.
Qu J; Qu X
Cancer Biomark; 2016 Jun; 17(1):49-54. PubMed ID: 27314292
[TBL] [Abstract][Full Text] [Related]
13. Individual tumor volume responses to short-course oxaliplatin-containing induction chemotherapy in locally advanced rectal cancer - Targeting the tumor for radiation sensitivity?
Flatmark K; Saelen MG; Hole KH; Abrahamsen TW; Fleten KG; Hektoen HH; Redalen KR; Seierstad T; Dueland S; Ree AH
Radiother Oncol; 2016 Jun; 119(3):505-11. PubMed ID: 26968754
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
Vallius T; Peter A; Auranen A; Carpén O; Kemppainen J; Matomäki J; Oksa S; Roering P; Seppänen M; Grénman S; Hynninen J
Gynecol Oncol; 2016 Jan; 140(1):29-35. PubMed ID: 26515076
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy efficacy and prognostic factors in 187 cervical cancer patients with IB2 and IIA2 stage.
Zou T; Zheng C; Zhang Z; Yu L; Fu C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 45(3):297-304. PubMed ID: 32386022
[TBL] [Abstract][Full Text] [Related]
16. [Risk factors of postoperative complication after total gastrectomy in advanced gastric cancer patients receiving neoadjuvant chemotherapy].
Cui H; Zhang KC; Cao B; Deng H; Liu GX; Cui JX; Xie TY; Liang WQ; Zhang QP; Wang N; Chen L; Wei B
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):153-159. PubMed ID: 33508921
[No Abstract] [Full Text] [Related]
17. Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer.
Lee J; Kim TH; Kim GE; Keum KC; Kim YB
J Gynecol Oncol; 2016 Sep; 27(5):e52. PubMed ID: 27329200
[TBL] [Abstract][Full Text] [Related]
18. Diffusion kurtosis imaging in the prediction of poor responses of locally advanced gastric cancer to neoadjuvant chemotherapy.
Fu J; Tang L; Li ZY; Li XT; Zhu HF; Sun YS; Ji JF
Eur J Radiol; 2020 Jul; 128():108974. PubMed ID: 32416553
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant Chemotherapy Followed by Chemoradiation in Cervical Carcinoma: A Review.
de Azevedo CR; Thuler LC; de Mello MJ; Ferreira CG
Int J Gynecol Cancer; 2016 May; 26(4):729-36. PubMed ID: 26905327
[TBL] [Abstract][Full Text] [Related]
20. Impact of neoadjuvant chemotherapy on surgical and pathological results of gastric cancer patients: A case-control study.
Charruf AZ; Ramos MFKP; Pereira MA; Dias AR; de Castria TB; Zilberstein B; Cecconelo I; Ribeiro U
J Surg Oncol; 2020 Apr; 121(5):833-839. PubMed ID: 31943232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
